ABSI
ABSI
NASDAQ · Biotechnology

Absci Corp

$10.03
-0.05 (-0.45%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 14 88%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +134.8% upside
Low Target $16.79
Average Target $23.55
High Target $35.63
Current Price $10.03
Current
$10.03
Target
$23.55
$16.79 $23.55 avg $35.63
Scenario Analysis
Bear Case
$16.79
67.4%
Low target
Base Case
$23.55
+134.8%
Avg target
Bull Case
$35.63
+255.2%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$8.17
22.8% from high
52-Week Low
$2.24
+347.8% from low
Target vs 52W High
$23.55
+188.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +5.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -46.4%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +191.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.5%